Aurum Metallicum 12X
Natural health product licensed in Canada
- Licence holder
- Weleda
- NPN or DIN-HM
- 80024234
- Status
- Active licence
- Licence date
- 15 March 2011
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aurum metallicum Source : Poudre d'or | 12 X | Not calculated |
Non-medicinal ingredients
Eau purifiée, Lactose, Ethanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 7 Goutte(s) ; maximum: 10 Goutte(s) | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Homeopathic Medicine. Homeopathic Remedy. Homeopathic Drug. Homeopathic Preparation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner before use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen. Patients should be advised to 1) consult with their health care practitioner to ensure that improvement is proceeding normally 2) store at controlled room temperature (60º 85º F) away from direct sunlight 3) keep tightly closed and out of reach of children.
- Contre-indications
Contraindicated with hypersensitivity to this product or any of its components.
Source
Official Health Canada record, licence 80024234
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.